Trial intelligence / Profile preview

Stoss Therapy of Vitamin D3 in General Surgery

NCT05650268Withdrawn

Sponsor
National Taiwan University Hospital
Start
Sep 2021
Primary completion
Apr 2022
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

Randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD) and postoperative complications (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Mortality rate at 30 days. Planned start Sep 2021; status: withdrawn.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)postoperative complications

Beyond the preview

Go deeper on NCT05650268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05650268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call